Publication | Closed Access

Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study

MedicinePharmacologyOne-institution StudyCombined Modality TreatmentAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung Cancer